Guardant Health Director Sells 1,300 Shares

Medina Manuel Hidalgo reduces stake by over 50%

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Guardant Health, Inc. (NASDAQ:GH) Director Medina Manuel Hidalgo sold 1,300 shares of the company's stock on March 6th, 2026. The shares were sold at an average price of $91.54, resulting in a total transaction of $119,002.00. Following the sale, Hidalgo's direct ownership in the company decreased by 52.15% to 1,193 shares, valued at approximately $109,207.22.

Why it matters

Insider transactions, such as this sale by a Guardant Health director, can provide insights into management's views on the company's prospects and valuation. Significant insider sales may signal concerns or a desire to diversify holdings, which could impact investor sentiment.

The details

Hidalgo's sale of 1,300 Guardant Health shares represents a 52.15% reduction in his direct ownership stake in the company. The shares were sold at an average price of $91.54, resulting in total proceeds of $119,002.00. Guardant Health is a precision oncology company that develops blood-based cancer diagnostics.

  • The share sale transaction occurred on Friday, March 6th, 2026.

The players

Medina Manuel Hidalgo

A director of Guardant Health, Inc.

Guardant Health, Inc.

A precision oncology company that develops blood-based cancer diagnostics.

Got photos? Submit your photos here. ›

The takeaway

This insider sale by a Guardant Health director could signal a shift in management's outlook on the company's valuation or future prospects, though more information would be needed to draw definitive conclusions. Investors should monitor any further insider transactions and financial performance to assess the potential impact on the stock.